Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial With the HIV Protease Inhibitor Indinavir for the Treatment of Classical Kaposi's Sarcoma

NCT00362310 is registered in ClinicalTrials.gov with Istituto Superiore di Sanità as lead sponsor.

NCT NCT00362310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00362310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial With the HIV Protease Inhibitor Indinavir for the Treatment of Classical Kaposi's Sarcoma
Lead sponsor
Istituto Superiore di Sanità
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2003
Completion date
July 31, 2007
Enrollment
28
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

classical kaposi's sarcoma